Coronavirus is a Money Maker! Everything is a Business Model....

Proctor and Gamble - that’s the one I thought of

Makes household cleaners and laundry detergent

Gonna be a whole lot more of hand and body and clothes washing ...

Biogen trading was halted today after climbing 28% with a possible vaccination to coronavirus. Imagine if you owned 100 shares of that stock when the market opened...

P&G is a cheap stock to own! Much cheaper than Clorox. That may be a good one to track!

My mistake. It was a different company I was thinking of. P&G is only up a Dollar this week, but that does hold potential...

most of the really profitable shares are not floated on the stock market.

You need to think differently. Can you take a chance on shorting airline stocks? American Airlines quit all flights to China. That has to have a negative effect on their stock over the next 30 days.

Can you short the Dry Baltic Index? Nothing will be moving out of China until the end of Feb. Shipping should be destroyed by then.

The 2nd largest economy in the world is on lock down. I'm a week late on shorting oil but I know that commodity will continue to fall for the next 30 days. There is a ton of $ to be made shorting oil alone!
Does anybody know a good medical supply company that imports to China?

That's all fine and dandy, but I want to know how to make $$$ off the SEE EYE AY killing off the Chinese. Is there a company that makes a China man killing machine that I can invest in?

Price of even the cheapest ineffective face masks have gone up through the stratosphere. Forget Bitcoin & stock market, when one can make a killing on useless masks eh.

errr nooooo

asx bit

The Directors of Biotron Limited (‘Biotron’ or ‘the Company’) are pleased to advise that it is in the process of evaluating several promising compounds for activity against coronavirus, including the new novel strain known as 2019-nCoV.

Within its proprietary small molecule compound library Biotron has over 30 compounds with good activity against a range of coronaviruses, including human coronaviruses that cause mild, cold-like symptoms as well as the SARS coronavirus that was responsible for the outbreak of that virus in 2003. These compounds can reduce the levels of coronavirus by 90 - 100% in infected cell cultures. Importantly, several compounds have broad-spectrum activity against multiple strains of coronaviruses.

In response to the recent coronavirus outbreak in China Biotron is now focused on testing a select set of these compounds against the new 2019-nCoV. This work will be done under contract in specialist laboratories that have access to this new virus, which has only been isolated and made available for such studies in recent days. Biotron’s priority will be testing its compounds that have shown broad-spectrum activity against different coronaviruses.

Biotron’s core expertise lies in the design and development of drugs that target virus-encoded proteins known as viroporins. The company’s scientists were the first to identify and publish data showing that the E protein of the coronavirus is viroporin and a good target for antiviral drugs. While Biotron’s focus has been on its lead clinical HIV-1 eradication and its promising preclinical Hepatitis B virus (HBV) programs, the company has continued to progress earlier stage research on development of drugs to target respiratory infections including coronaviruses.